
Abstract 3726: Preclinical activity of PSMA-TTC (BAY 2315497) in combination with androgen receptor antagonists in prostate cancer models
Author(s) -
Stefanie Hammer,
Urs B. Hagemann,
Sabine Zitzmann-Kolbe,
A Dawson Larsen,
Chrstine Ellingsen,
Oliver von Ahsen,
Jenny Karlsson,
Roger M. Bjerke,
Olav B. Ryan,
Pascale Lejeune,
Hartwig Hennekes,
Alan Cuthbertson,
Dominik Mumberg
Publication year - 2019
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 1.055
H-Index - 84
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2019-3726
Subject(s) - enzalutamide , prostate cancer , medicine , lncap , cancer research , androgen receptor , cancer , in vivo , pharmacology , biology , microbiology and biotechnology